NO930946D0 - Doseringsaerosoler som inneholder virkestoffet flezelastin og forbindelser av beslektet natur - Google Patents

Doseringsaerosoler som inneholder virkestoffet flezelastin og forbindelser av beslektet natur

Info

Publication number
NO930946D0
NO930946D0 NO930946A NO930946A NO930946D0 NO 930946 D0 NO930946 D0 NO 930946D0 NO 930946 A NO930946 A NO 930946A NO 930946 A NO930946 A NO 930946A NO 930946 D0 NO930946 D0 NO 930946D0
Authority
NO
Norway
Prior art keywords
flezelastine
relationships
active substance
containing active
aerosols containing
Prior art date
Application number
NO930946A
Other languages
English (en)
Other versions
NO930946L (no
Inventor
Helmut Hettche
Juergen Engel
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of NO930946D0 publication Critical patent/NO930946D0/no
Publication of NO930946L publication Critical patent/NO930946L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO93930946A 1992-03-17 1993-03-16 Doseringsaerosoler som inneholder virkestoffet flezelastin og forbindelser av beslektet struktur NO930946L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4208545 1992-03-17

Publications (2)

Publication Number Publication Date
NO930946D0 true NO930946D0 (no) 1993-03-16
NO930946L NO930946L (no) 1993-09-20

Family

ID=6454293

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93930946A NO930946L (no) 1992-03-17 1993-03-16 Doseringsaerosoler som inneholder virkestoffet flezelastin og forbindelser av beslektet struktur

Country Status (12)

Country Link
EP (1) EP0561166A1 (no)
JP (1) JPH0616539A (no)
KR (1) KR930019204A (no)
CN (1) CN1080852A (no)
AU (1) AU3526193A (no)
BR (1) BR9301172A (no)
CA (1) CA2091713A1 (no)
FI (1) FI931159A (no)
HU (1) HU9300747D0 (no)
MX (1) MX9301410A (no)
NO (1) NO930946L (no)
ZA (1) ZA931875B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635159A (en) * 1994-08-26 1997-06-03 Abbott Laboratories Aerosol drug formulations containing polyglycolyzed glycerides
GB9426252D0 (en) * 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
JP4824267B2 (ja) * 2001-03-30 2011-11-30 ヤゴテック アーゲー 医療用エアゾール配合物
ES2259915B1 (es) * 2005-03-15 2007-12-16 Laboratorio Aldo-Union, S.A. Nueva formulacion estable de aerosoles en suspension y procedimiento de obtencion.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3677322D1 (de) * 1985-11-11 1991-03-07 Asta Pharma Ag 4-benzyl-1-(2h)-phthalazinon-derivate.

Also Published As

Publication number Publication date
CA2091713A1 (en) 1993-09-18
EP0561166A1 (de) 1993-09-22
JPH0616539A (ja) 1994-01-25
CN1080852A (zh) 1994-01-19
AU3526193A (en) 1993-09-23
HU9300747D0 (en) 1993-05-28
FI931159A (fi) 1993-09-18
FI931159A0 (fi) 1993-03-16
ZA931875B (en) 1993-10-06
NO930946L (no) 1993-09-20
MX9301410A (es) 1993-09-01
KR930019204A (ko) 1993-10-18
BR9301172A (pt) 1993-09-21

Similar Documents

Publication Publication Date Title
NO305802B1 (no) Nye forbindelser, farmas°ytiske blandinger inneholdende disse og anvendelse av disse forbindelser
NO307864B1 (no) Farmasøytisk aerosolformulering, boks og doseringsinhalator
PL300347A1 (en) Cyclic urea derivatives, therapeutic agents containing them and method of obtaining sames
NO303638B1 (no) Kondenserte indolderivater, farmas°ytiske preparater inneholdende disse og anvendelse av derivatene
DE69124274T2 (de) Oligopeptide, sie enthaltende pharmazeutische und Futterzusammensetzung und Benützung von Oligopeptiden
PT100960A (pt) Sulfonil-ureias e carbamatos inibidores de acil-coa: colesterol-aciltransferase (acat) e composicoes farmaceuticas contendo estes compostos
ID22523A (id) Formulasi aerosol obat yang mengandung budesonida
NO920509D0 (no) Overflateaktive cykliske amidokarboksyforbindelser, syntese og anvendelse av forbindelsene
FI942351A (fi) Aromien kapselointi
NO951880D0 (no) Anordning til innånding av pulver
DE69309571T2 (de) Fehlerdiffusion hoher Adressierbarkeit und minimaler Markengrösse
PL308361A1 (en) Novel taxane derivatives, method of obtaining them and pharmaceutical agents containing such derivatives
NO950889L (no) Nanopartikler inneholdende et virksomt stoff og et polyketalvinsyreamid, fremgangsmåter for fremstilling derav og anvendelse av partiklene
DK127691D0 (da) Mucoadhaesivt baerestof og farmaceutisk doseringsform indeholdende dette baerestof
IT1173708B (it) Dispositivo chirurgico contenente sostanza farmaceutica ed emissione protratta
NO930946D0 (no) Doseringsaerosoler som inneholder virkestoffet flezelastin og forbindelser av beslektet natur
HUT51854A (en) Insecticides containing as active substance derivatives of chrisanthemate
NO932283D0 (no) Farmasoeytiske preparater inneholdende amidinforbindelser og nye amidiner
NO933237D0 (no) Absorbat av en hjelpestoffblanding og et ikke-fast virksomt stoff for fremstilling av legemiddelpreparater
FI932786A0 (fi) Vaikuttavaa ainetta luovuttava laite
GB9310524D0 (en) New formulations of active substances for plant protection and methods for the use thereof
NO169182C (no) Doseringsbeholder for opptak og levering av midler for behandling av toey.
PL297065A1 (en) Active substance containing preparation and method of obtaining same
JPS5755869A (en) Package of insecticide and deodorizer
NO885164D0 (no) Fremgangsmÿte og anordning for dosering av pulver.